Tag
Tag: CAR-T
Celyad Starts a Third CAR-T Trial, in Metastatic Colorectal Cancer
Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns
Cutting Through the BS in Biopharma: How To Spot Hype
Servier Recruits Viral Vector Expert to Step Up its CAR-T Technology
UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic
New Results from Novartis in the Race to Launch the First CAR-T
British Biotech Tops up its Cancer Pipeline with New TCR Therapy
Celyad Reports Impressive Preliminary CAR-T Results in Solid Tumors
New Public-Private French Collaboration will Develop CAR-Tregs
Novartis Gains Access to Celyad’s allogenic CAR-T cell patents
